7 things to keep in mind when adopting flow chemistry

NEAL MUNYEBVU | October 5, 2018

article image
Sometimes the biggest hurdle for chemists adopting flow chemistry is the time it takes to convert a batch process into a seamless flow set-up – but it doesn’t have to be! Whether you want gradual or immediate adoption, this post covers the 7 main things you should consider when you are looking to convert your batch process into continuous flow.

Spotlight

Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

OTHER ARTICLES

NON-CHEMICAL WEED CONTROL WITH FOAMSTREAM

Article | February 21, 2020

Unwanted weeds and vegetation don’t have to be controlled with harmful and dangerous chemicals. There are plenty of non-chemical and organic methods of weed control that are reliable and safe to use, such as Foamstream. Non-chemical weed control is the process of killing weeds without harmful toxins. This is sometimes referred to as cultural or organic weed control, with methods ranging from hoeing and hand-pulling, to hot water and of course, Foamstream.

Read More

Petrochemicals in PA: What You Need to Know

Article | February 19, 2020

A bill recently passed by the Pennsylvania General Assembly would subsidize the use of fracked gas to produce petrochemicals. At some point—i.e., at a time chosen by the state Senate—H B 1100 will be sent to Governor Wolf, who has promised a veto despite override threats. Meanwhile, Pennsylvanians are trying to understand the bill and its potential impacts. That hasn't been easy, because as with the petrochemical subsidy bills Pennsylvania enacted in 2012, the General Assembly has not held a single hearing on the legislation. The purpose of this blog is to help fill that gap.

Read More

COVID-19: Managing disruption in the chemical industry

Article | March 30, 2020

The chemical industry is no stranger to disruption, from SARS to trade policy conflict and the financial crisis. Yet COVID-19 is unprecedented in its impact, creating a universal imperative for governments and businesses to take immediate action to protect their people. Unlike many other sectors, the chemical industry is not in a position to stop production and send workers home. Instead, it needs to strike the right balance between “social distancing” and keeping plants running to provide the basic necessities for society, as well as the antiseptics, disinfectants, protective packaging and more needed to fight the pandemic.

Read More

5 Biggest Pesticide Companies Are Making Billions From 'Highly Hazardous' Chemicals, Investigation Finds

Article | February 20, 2020

The analysis shows that the world's top five pesticide makers are making billions, accounting for more than 36 percent of their income, from chemicals that are proven to hazards to humans and the environment and are contributing to the precipitous demise of bee populations, as Unearthed reported. The researchers found that the sale of these highly hazardous pesticides (HHPs), disproportionately occurred in poorer nations, which often have fewer regulations than industrialized nations, according to The Guardian. In India, for example, sales of HHPs were nearly 60 percent, while in the UK it was just 11 percent.

Read More

Spotlight

Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

Events